Case Study – Quick Look up at DCGI approval of Lundbeck’s Brintellix
Posted on15 Oct 2018
TagsBrintellix, CDSCO, codevelopment deal in pharma, comarketing deal in pharma, copromotion deal in pharma, DCGI, Lundbeck, vortioxetine
Comments0
Lundbeck India Private Limited (LIPL) announces the launch of Brintellix (vortioxetine) in India for the treatment of patients suffering from major depressive... Read More
DRL to disinvest antibiotics plant to Abu Dhabi-based Neopharma
Dr Reddy’s Laboratories on Monday announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee... Read More
Tildrakizumab (Ilumetri): Discovery, Development to Commercialization Case Study
Brand Name: Ilumetri Biomolecule: Tildrakizumab Tildrakizumab was designed to block interleukin-23, a cytokine that plays an important role in managing the immune... Read More
Pharma aaquisition: Aurobindo to acquire dermatology and oral solids businesses from Sandoz Inc. for $900 million
Aurobindo Pharma’s US based subsidiary Aurobindo Pharma USA Inc has entered into a definitive agreement with Sandoz Inc., USA, a Novartis division,... Read More
Market Launch and brand positioning of Volini Maxx
Posted on30 Aug 2018
Comments0
Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Ltd, has launched Volini Maxx, a strongest pain relief spray. The company... Read More
Grünenthal’s Duzallo: EU marketing authorization and Brand Positining
Duzallo EU Marketing Authorization Grünenthal announced that the European Commission (EC) has followed the positive opinion of the Committee for Medicinal Products... Read More
Digital Strategy for pharma brand promotion: Merck launch map4health
Posted on21 Aug 2018
Comments0
Healthy Interactions, a global leader in health education, in collaboration with Merck, known as MSD outside the United States and Canada, announced... Read More
Brand Promotion: Mankind’s OTC brand KABZEND
Mankind Pharma, a quality-driven pharmaceutical company in India, has launched a new over-the-counter (OTC) product – KABZEND Natural Laxative Granules to help... Read More
Case Study on USFDA Label Expansion: Novartis’ Kisqali
FDA had approved Kisqali in tandem with an aromatase inhibitor as an initial endocrine-based treatment for pre, peri- or postmenopausal women with... Read More
DRL launches generic Nexium 24HR capsules in US market
Dr Reddy’s Laboratories Ltd. announced the launch of the US Food and Drug Administration (FDA) approved esomeprazole magnesium delayed-release capsules USP, 20... Read More